If the editor was not aware of the violations and of the fact that the article had already been published, the editor will announce in the journal that the submitted manuscript had already been published in a duplicate or redundant manner, without seeking the author’s explanation or approval. If redundant or duplicate publication is attempted or occurs without such notification, the submitted manuscript will be rejected immediately. The new manuscript should be submitted together with copies of the duplicate or redundant material to the editorial committee. Under these conditions, any such work should be referred to and referenced in the new paper. If a paper that might be regarded as duplicate or redundant had already been published in another journal or submitted for publication, the author should notify the fact in advance at the time of submission. Upon receipt, submitted manuscripts are screened for possible plagiarism or duplicate publication using Crossref Similarity Check. Redundant or duplicate publication refers to the publication of a paper that overlaps substantially with one already published. Originality, Plagiarism, and Duplicate Publication In particular, all sources of funding applicable to the study should be explicitly stated. Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. When submitting the manuscript, the author must attach the letter of conflict of interest statement ( ). The author is responsible for disclosing any financial support or benefit that might affect the content of the manuscript or might cause a conflict of interest. If necessary, the editor or reviewers may request copies of these documents to resolve questions regarding IRB/IACUC approval and study conduct. For research with animal subjects, studies should be approved by an Institutional Animal Care and Use Committee (IACUC). Clinical studies with human subjects should provide a certificate, an agreement, or the approval by the Institutional Review Board (IRB) of the author’s affiliated institution. Statement of Informed Consent and Institutional ApprovalĬopies of written informed consent should be kept for studies on human subjects. The ethical treatment of all experimental animals should be maintained. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals. For human subjects, identifiable information, such as patients’ names, initials, hospital numbers, dates of birth, and other protected health care information, should not be disclosed. Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. The Korean Journal of Internal Medicine follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals ( ) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA ) if not described otherwise.Ĭlinical research should be conducted in accordance with the World Medical Association’s Declaration of Helsinki ( ). PUBLICATION TYPES, QUALIFICATION FOR AUTHORS AND LANGUAGE
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |